Lack of effect of bromocriptine on ACTH levels in patients with bilateral adrenalectomy for pituitary-dependent Cushing's syndrome
- PMID: 229153
- DOI: 10.1007/BF03350982
Lack of effect of bromocriptine on ACTH levels in patients with bilateral adrenalectomy for pituitary-dependent Cushing's syndrome
Abstract
Bromocriptine lowers plasma ACTH levels in patients with pituitary-dependent Cushing's syndrome. It seemed possible that the drug would also be effective in patients who had been adrenalectomised for the disease. The effect of 5.0 mg of bromocriptine on plasma ACTH and prolactin levels in 13 patients, bilaterally adrenalectomised for pituitary-dependent Cushing's syndrome, was therefore studied. In only one patient was a fall in plasma ACTH observed. This may be of doubtful significance since marked spontaneous fluctuation in plasma ACTH levels were found in the five patients tested. Bromocriptine lowered the plasma prolactin in all of the patients, including two with hyperprolactinaemia.
Similar articles
-
The effect of cyproheptadine and/or bromocriptine on plasma ACTH levels in patients cured of Cushing's disease by bilateral adrenalectomy.Clin Endocrinol (Oxf). 1990 Feb;32(2):193-201. doi: 10.1111/j.1365-2265.1990.tb00855.x. Clin Endocrinol (Oxf). 1990. PMID: 2161298
-
ACTH and cortisol response to bromocriptine, and results of long-term therapy, in Cushing's disease.Acta Endocrinol (Copenh). 1978 Nov;89(3):461-8. doi: 10.1530/acta.0.0890461. Acta Endocrinol (Copenh). 1978. PMID: 212917 Clinical Trial.
-
Follow-up study on treatment in 27 patients with Cushing's disease: adrenalectomy, transsphenoidal adenomectomy and medical treatment.Endocrinol Jpn. 1981 Apr;28(2):197-205. doi: 10.1507/endocrj1954.28.197. Endocrinol Jpn. 1981. PMID: 6273138
-
Evaluation and treatment of Cushing's syndrome.Am J Med. 2005 Dec;118(12):1340-6. doi: 10.1016/j.amjmed.2005.01.059. Am J Med. 2005. PMID: 16378774 Review.
-
A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome.Eur J Endocrinol. 2015 Oct;173(4):M23-32. doi: 10.1530/EJE-15-0265. Epub 2015 May 20. Eur J Endocrinol. 2015. PMID: 25994948 Review.
Cited by
-
Effects of bromocriptine on pituitary tumour size.Br Med J. 1979 Sep 22;2(6192):700-3. doi: 10.1136/bmj.2.6192.700. Br Med J. 1979. PMID: 509071 Free PMC article.
-
Management of Nelson's Syndrome.Medicina (Kaunas). 2022 Nov 2;58(11):1580. doi: 10.3390/medicina58111580. Medicina (Kaunas). 2022. PMID: 36363537 Free PMC article. Review.
-
Long term bromocriptine therapy in Cushing's disease.J Endocrinol Invest. 1982 Mar-Apr;5(2):117-20. doi: 10.1007/BF03350502. J Endocrinol Invest. 1982. PMID: 6284830
-
Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations.Eur J Endocrinol. 2021 Mar;184(3):P1-P16. doi: 10.1530/EJE-20-1088. Eur J Endocrinol. 2021. PMID: 33444221 Free PMC article.
-
Direct effects of thyrotropin-releasing hormone, cyproheptadine, and dopamine on adrenocorticotropin secretion from human corticotroph adenoma cells in vitro.J Clin Invest. 1981 Oct;68(4):1018-27. doi: 10.1172/jci110324. J Clin Invest. 1981. PMID: 6270192 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources